| Drug
safety advice |
|
•
|
SSRIs
and SNRIs: risk of persistent pulmonary hypertension in the newborn |
|
•
|
Antidepressants:
risk of fractures |
|
•
|
Carbapenems:
concomitant use with valproic acid not recommended |
|
•
|
Oral
tacrolimus products: measures to reduce the risk of medication errors
|
|
•
|
Simvastatin:
increased risk of myopathy at high dose (80 mg) |
| Stop
Press |
|
•
|
Panitumumab
(Vectibix): serious hypersensitivity reactions |
| Other
information from the MHRA |
|
•
|
Patient
information leaflet of the month: Durogesic DTrans Transdermal Patch |
